Developer of a patient experience management platform designed to automate patient appointments.
Developer of a patient experience management platform designed to automate patient appointments.
Discovery Tools (Healthcare)📍 Bolton, United KingdomFounded 2022
Current Valuation
$1.0B
as of 2022-Q2
UNICORN
QL Price
$267.11M
-73% vs last round
QuantLogix's current estimate for NexHealth, published 2026-11-12 — below the last disclosed round of $1.0B (2022-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.0B
2022-Q2
weight 0.05
Secondary market print
$187M
2026-06-27
weight 0.44
How this price has held up
No round has priced for NexHealth since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-11-12 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, NexHealth, 2026-11-12 (8188687d4cb1f0e6).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is NexHealth going public?
No. NexHealth is private and has not filed to go public. There is no S-1 on file.
What is NexHealth's valuation in 2026?
NexHealth is valued at $1.0B as of 2022-Q2, set by its Series C ($125M, Apr 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has NexHealth filed an S-1?
No public S-1 is on file for NexHealth.
How much has NexHealth raised?
NexHealth has raised $177.71M in total, most recently a Series C of $125M in Apr 2022.
Is NexHealth publicly traded — can you buy NexHealth stock?
No. NexHealth is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for NexHealth on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2022
HQ
Bolton, United Kingdom
Employees
6
Total Raised
$177.71M
Last Round
Series C — $125M (Apr 2022)
IPO Status
private
Fundraising Status
Series C · $125M · 4y 7mo ago
privateTotal raised $177.71M
Secondary Market
Implied price / share
$2.65
Last round price / share
$14.18
vs last round
-81.3%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$125M
Apr 2022
—
$1.0B
Talent Signal
Hiring trend
▲ Hiring uptrend
+10% vs 2026-09
Open roles
69
via greenhouse
Product-build share
39%
engineering, research, product, design
Trajectory
expanding
balanced build + GTM — 39% builders vs 61% go-to-market/G&A — scaling both sides.
No tracked executive churn; open roles trending up.
Counted from NexHealth's live job board as of 2026-10-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
SoftwareHealth CareElectronic Health Record (EHR)
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.